Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
BACKGROUND: Few studies have investigated objective markers of lipodystrophy in African children. We compared body circumferences, skin-fold thickness (SFT) and lipids in antiretroviral therapy (ART)-naive and stavudine (d4T)-exposed children with HIV-uninfected controls. METHODS: In the CHAPAS-3 tr...
Main Authors: | Musiime, V, Cook, A, Kayiwa, J, Zangata, D, Nansubuga, C, Arach, B, Kenny, J, Wavamunno, P, Komunyena, J, Kabamba, D, Asiimwe, A, Mirembe, G, Abongomera, G, Mulenga, V, Kekitiinwa, A, Kityo, C, Walker, SA, Klein, N, Gibb, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
by: Mulenga, V, et al.
Published: (2016) -
Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa
by: Abongomera, G, et al.
Published: (2016) -
Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
by: Bwakura-Dangarembizi, M, et al.
Published: (2015) -
Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children
by: Kekitiinwa, A, et al.
Published: (2016) -
Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda
by: Imelda K Tamwesigire, et al.
Published: (2024-03-01)